MedPath

BOEHRINGER INGELHEIM LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

126

Active:126
Completed:0

Trial Phases

1 Phases

Phase 1:95

Drug Approvals

38

EMC:38

Drug Approvals

Jardiance 25 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Viramune 50mg/5ml oral Suspension

Approval Date
Jul 7, 2025
EMC

Vargatef 150 mg soft capsules

Approval Date
Jul 7, 2025
EMC

Atrovent UDVs, 2 ml

Approval Date
Jul 7, 2025
EMC

Jardiance 10 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

MIRAPEXIN 0.088 mg tablets

Approval Date
Jul 7, 2025
EMC
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

Distribution across different clinical trial phases (95 trials with phase data)• Click on a phase to view related trials

Phase 1
95 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.